Skip to main content

Table 1 Overall prevalence of HPV types found in Mexican women according to type of lesion and normal cytology

From: Prevalence of human papillomavirus in the cervical epithelium of Mexican women: meta-analysis

Type

CC

 

HSIL

 

LSIL

 

Normal

All

HPV

n

%

N

%

N

%

N

%

N

%

6*

5

1.00

3

0.82

35

2.46

26

0.41

69

0.79

11*

2

0.40

4

1.10

9

0.63

39

0.61

54

0.62

13***

0

0.00

0

0.00

1

0.07

1

0.02

2

0.02

16**

315

63.13

103

28.30

188

13.19

221

3.44

827

9.50

18**

43

8.62

27

7.42

61

4.28

78

1.22

209

2.40

26***

0

0.00

1

0.27

0

0.00

0

0.00

1

0.01

31**

25

5.01

20

5.49

21

1.47

39

0.61

105

1.21

32***

0

0.00

0

0.00

2

0.14

4

0.06

6

0.07

33**

5

1.00

24

6.59

106

7.44

138

2.15

273

3.14

34***

0

0.00

0

0.00

0

0.00

2

0.03

2

0.02

35**

2

0.40

2

0.55

5

0.35

12

0.19

21

0.24

39**

4

0.80

4

1.10

2

0.14

12

0.19

22

0.25

40*

0

0.00

0

0.00

1

0.07

5

0.08

6

0.07

42*

0

0.00

1

0.27

0

0.00

1

0.02

2

0.02

44***

0

0.00

0

0.00

0

0.00

1

0.02

1

0.01

45**

20

4.01

3

0.82

28

1.96

32

0.50

83

0.95

51**

1

0.20

4

1.10

5

0.35

12

0.19

22

0.25

52**

6

1.20

2

0.55

8

0.56

14

0.22

30

0.34

53***

2

0.40

2

0.55

16

1.12

59

0.92

79

0.91

54*

0

0.00

0

0.00

2

0.14

5

0.08

7

0.08

55***

0

0.00

1

0.27

0

0.00

0

0.00

1

0.01

56**

3

0.60

7

1.92

6

0.42

3

0.05

19

0.22

57***

0

0.00

0

0.00

0

0.00

2

0.03

2

0.02

58**

25

5.01

46

12.64

38

2.67

79

1.23

188

2.16

59**

5

1.00

5

1.37

7

0.49

12

0.19

29

0.33

61*

0

0.00

2

0.55

8

0.56

33

0.51

43

0.49

62***

0

0.00

0

0.00

9

0.63

15

0.23

24

0.28

66***

1

0.20

5

1.37

7

0.49

13

0.20

26

0.30

67***

2

0.40

1

0.27

0

0.00

0

0.00

3

0.03

68**

1

0.20

0

0.00

0

0.00

8

0.12

9

0.10

69***

9

1.80

0

0.00

4

0.28

6

0.09

19

0.22

70*

0

0.00

2

0.55

4

0.28

24

0.37

30

0.34

71***

0

0.00

0

0.00

6

0.42

17

0.26

23

0.26

72*

0

0.00

0

0.00

1

0.07

3

0.05

4

0.05

73**

0

0.00

2

0.55

0

0.00

1

0.02

3

0.03

81*

0

0.00

4

1.10

10

0.70

28

0.44

42

0.48

82**

0

0.00

0

0.00

1

0.07

1

0.02

2

0.02

83***

0

0.00

0

0.00

4

0.28

6

0.09

10

0.11

84***

0

0.00

0

0.00

4

0.28

2

0.03

6

0.07

85***

0

0.00

0

0.00

0

0.00

3

0.05

3

0.03

87***

0

0.00

0

0.00

0

0.00

1

0.02

1

0.01

89***

0

0.00

0

0.00

1

0.07

4

0.06

5

0.06

90***

0

0.00

0

0.00

0

0.00

4

0.06

4

0.05

97***

0

0.00

0

0.00

0

0.00

1

0.02

1

0.01

102***

0

0.00

0

0.00

1

0.07

0

0.00

1

0.01

negatives

23

4.61

89

24.45

824

57.82

5,451

84.93

6,387

73.36

Total

499

100.00

364

100.00

1,425

100.00

6,418

100.00

8,706

100.00

  1. n = number of samples; %: frequency; CC: cervical carcinoma, HSIL: high-grade squamous intraepithelial lesion, LSIL: low grade squamous intraepithelial lesion, Normal: Women without lesion and normal cytology. *: HPV Low risk (no oncogenic potential); **: HPV high risk (oncogenic potential); ***: HPV without sufficient epidemiological evidence to know their risk of oncogenesis [2].